consecutive men with localized PCA and documented invasion of the prostatic apex underwent RPP by a single surgeon. Soft tissue biopsies were systematically obtained from the prostatic fossa overlying the apex at the time of surgery. Time to biochemical failure was calculated using the Kaplan-Meier method. The rates of positive apical margins and positive apical soft tissue biopsies were 23.4% (18/77) and 15.6% (12/77). The sensitivity, specificity and positive predictive value of positive apical margins for residual apical disease as determined by apical soft tissue biopsy were 41.7, 80, and 28%, respectively. The overall biochemical failure rate was 28.6% (22/77) with a median follow-up of 51 months (range 3-73 months). The 36-month biochemical recurrence-free survival rate was 55.9714.9% for patients with positive apical biopsies and 78.775.3% for those with negative biopsies (P ¼ 0.023). In conclusion, positive apical soft tissue biopsy is an independent predictor of biochemical failure in patients with apical PCA who undergo RPP. Positive apical surgical margins poorly predict residual apical disease that is frequently identifiable by apical soft tissue biopsy. Apical soft tissue biopsies should therefore be obtained in patients with known extensive apical cancer involvement at the time of RPP.
Introduction
The apex of the prostate is one of the most common sites for positive margins in patients undergoing radical prostatectomy. [1] [2] [3] Reasons suggested for this high sitespecific positive margin rate include the lack of a true anatomic prostatic capsule at the apex, the proximity of the urethral continence mechanism requiring a close surgical margin and the difficulty in obtaining surgical exposure within a constricted space. 3 Although the significance of positive surgical margins at the apex of the prostatectomy specimen in predicting residual apical disease and biochemical failure remains controversial, 2, 4, 5 several authors have proposed modifications of the retropubic technique to lower the apical positive margin rate. 6, 7 With radical perineal prostatectomy (RPP), positive apical surgical margins are thought to occur less frequently because of better visualization and easier access to the apex of the prostate. 3, [8] [9] [10] Few studies have specifically addressed the issue of apical margins in RPP. We present here a prospective assessment of the prognostic significance of apical surgical margins and soft tissue biopsies in patients with documented apical prostate cancer (PCA).
3,11

Materials and methods
Between June 1998 and May 1999, 82 consecutive RPP candidates with clinically localized PCA and apical tumor involvement were prospectively identified. All patients had undergone sextant biopsy of the prostate with a least one positive biopsy core from the prostatic apex. In these patients, RPP was performed by a single experienced surgeon (DFP) using a standardized, widefield dissection technique with bilateral resection of the neurovascular bundles. 12 Nerve-sparing was not considered at the time because patients with bilateral apical involvement were considered at high risk for local apical extension and neurovascular involvement. Up to three intraoperative soft tissue biopsies from the lateral apical prostatic fossa and/or the urethral stump, inclusive of circumferential periurethral tissue (see Figure 1) , were submitted for permanent section pathology. The prosta-tectomy specimen was inked and processed according to a standard protocol as described by Bostwick and Foster. 13 Specifically, the apex was evaluated by amputation of the distal 1 cm of the prostate in the form of a cone and subsequently step-sectioned. The apical specimen was initially inspected to confirm tumor involvement of the apex and patients without evidence of PCA in the apex were excluded. A positive margin was defined as the presence of PCA cells touching the inked margin. A single experienced uropathologist (JFM) reviewed all specimens and determined surgical margin and soft tissue biopsy status, in addition to Gleason score, prostate size, tumor volume and pathologic stage according to the revised 1997 TNM system. 14 Patients were followed routinely for clinical, biochemical and radiographic evidence of disease recurrence at 6 weeks and subsequently at 6 months intervals. Biochemical failure was defined as a prostate-specific antigen (PSA) level 0.4 ng/ml or greater measured at least 4 weeks after RPP. 15 The date of last follow-up considered in this analysis was 30 September 2004. This study was formally approved by our Institutional Review Board.
Statistical analysis was performed using SPSS 12.0 (SPSS Inc., Chicago, IL, USA). Descriptive statistics were applied to continuous variables to examine distribution and variance. Statistical comparisons were made using parametric and non-parametric ANOVA, the Student's ttest and the Wilcoxon rank-sum test as appropriate. Categorical variables were analyzed using the Pearson w 2 test. Time to biochemical failure was calculated by the Kaplan-Meier method and compared using the log-rank test. 16 Multivariate analysis was performed using a proportional hazards model. 17 A two-sided a of 0.05 was considered significant in all analyses. No formal adjustment for multiple comparisons was performed.
Results
Of 82 consecutive patients, five lacked evidence of apical PCA in the prostatectomy specimen and were excluded.
Our study population therefore consisted of 77 RPP patients with clinically localized PCA. Patient characteristics are summarized in Table 1 . Median age was 63 years (range 41-76), median preoperative PSA was 6.4 ng/ml (range 1.0-39.0) and the median tumor volume was 4.8 cm 3 (range 0.4-31.2). Approximately two-thirds of patients (67.5%; 52/77) had bilateral apical PCA. The rates of positive apical margins and positive apical soft tissue biopsies were 23.4% (18/77) and 15.6% (12/77). Positive apical margins were correlated with positive biopsies from the corresponding location of the prostatic fossa in 27.8% (5/18) of cases. In seven patients, apical soft tissue biopsies were positive despite negative apical margins ( Table 2 ). The sensitivity, specificity and positive predictive value of a positive apical margin for residual apical disease as determined by apical soft tissue biopsy were 41.7, 80 and 28%, respectively.
The relationship of apical margin status and apical soft tissue biopsy status to other clinical and pathological parameters was also studied. Positive apical surgical margins represented an isolated positive margin in half of the cases (9/18 patients). Patients with positive apical margins had higher preoperative PSA (P ¼ 0.009), greater tumor volume (P ¼ 0.005) and increased incidence of (Table 3 ). In addition, nonsignificant trends toward more advanced Gleason score, increased incidence of extracapsular extension and increased peripheral margin positivity were observed. The presence of a positive apical soft tissue biopsy was associated with an increased rate of extracapsular extension and a higher rate of peripheral positive margins.
To analyze the association between apical margin status and cancer outcome, we examined long-term biochemical failure rates. The overall biochemical failure rate in our study was 28.6% (22/77) at a median length of follow-up of 51 months (range 3-73 months). Three patients (3.9%) were elected to undergo adjuvant treatment in the form of local radiation (n ¼ 2) or antiandrogen treatment (n ¼ 1) in the absence of documented recurrence and an additional three patients (3.9%) died of unrelated causes with an undetectable PSA and no evidence of disease. Progression-free survival after 36 months was 75.275.1%.
Univariate analysis demonstrated no significant difference in the time to biochemical failure of patients with or without positive apical margins (Table 4) . In contrast, patients with a positive apical soft tissue biopsy were significantly more likely to experience biochemical failure ( Figure 2 ) than patients with a negative biopsy (HR 2.8; CI 1.1-7.3). Thirty-six-month recurrence-free survival rates were 55.9714.9% for those with a positive biopsy and 78.775.3% for those with negative biopsies (P ¼ 0.023). A higher Gleason score, positive peripheral margins, extracapsular extension and elevated preoperative PSA levels were also univariate predictors of biochemical failure. In a multivariate proportional hazards model incorporating each of these factors, negative apical soft tissue biopsy status (P ¼ 0.037), lower Gleason score (P ¼ 0.001) and lower PSA (P ¼ 0.043) were independent predictors of increased time to biochemical failure. Negative apical surgical margin status was not significantly associated with decreased disease recurrence (P ¼ 0.472).
Discussion
The specific aim of this study was to prospectively evaluate the prognostic significance of positive apical margins and positive apical soft tissue biopsies in patients undergoing RPP. Several design characteristics of this study deserve special consideration. First, only patients with documented apical cancer involvement as determined by prior sextant biopsy were included, thereby increasing the risk of positive apical margins. Second, all patients underwent a wide-field dissection as described previously and no attempt to preserve the neurovascular bundles was made. 12 Finally, systematic apical soft tissue biopsies were obtained intraoperatively as a surrogate marker for residual local disease. Whereas previous studies have addressed the issue of positive apical margins in RPP patients, this study is the first to compare apical margin status directly with apical soft tissue biopsies in RPP. 1, 3, 11 The two main findings of our study are that apical margin and apical soft tissue status are poorly correlated and that apical soft tissue status predicts biochemical failure whereas apical surgical margin status does not.
Based on the observation that the apical surgical margin was falsely negative by soft tissue biopsy in Apical margins in RPP HR Kübler et al seven of 12 patients and the fact that the positive predictive value of a positive apical surgical margin is low, we conclude that apical surgical margin status is of limited value in predicting residual apical disease and clinical outcome. In our study, the positive apical soft tissue biopsy rate was 15.6% (12/77). In a similar study of a radical retropubic prostatectomy (RRP) cohort, Shah et al. 18 found PCA in only 7.4% (7/95) of apical soft tissue biopsies. This discrepancy, however, may be attributable to the fact that the RRP study did not assess for the presence of apical cancer involvement and therefore did not exclude patients without apical PCA. Nevertheless, sensitivity, specificity and positive predictive value of a positive apical margin were similarly low with values of 57, 86 and 25%, respectively. As such, positive apical surgical margins appear to be poor predictors of residual disease at the apex in both RRP and RPP.
Whether a positive margin at the apex represents an independent predictor of cancer outcome when controlling for other prognostic variables has previously been addressed in a study by Fesseha et al. 5 Based on a small study of 33 patients with a median follow-up of 39 months, there was no significant difference in biochemical failure rates between patients with margin negative, organ-confined disease and patients with an isolated positive apical margin. The authors concluded that the prognostic significance of positive apical margins in previous reports may have been confounded by the extent of disease elsewhere, a possibility supported by our RPP results. As in previous studies, we found an association between positive apical margins and larger tumor volume, elevated preoperative PSA and positive bladder neck margins. 2, 19 To determine the clinical relevance of apical soft tissue biopsy, we assessed their prognostic significance in both univariate and multivariate analyses. Whereas univariate analyses identified several prognostic variables, only apical soft tissue biopsies, bladder neck margins and peripheral margins remained independent predictors of biochemical failure in our proportional hazards model. By contrast, extracapsular extension and advanced Gleason score -both established markers of potential disease recurrence after radical prostatectomy -did not predict biochemical failure in the presence of covariables. These findings are consistent with the idea that incomplete resection and residual disease are associated with early biochemical failure, whereas grade and stage are more predictive of long-term outcome. In our study, the documented positive apical tissue biopsies suggest that residual local disease may account for some cases of biochemical failure.
Our study has several limitations that deserve consideration. First, our study population was relatively small, limiting statistical power and subset analysis. In addition, follow-up was relatively short and biochemical failure was used as a surrogate measure of outcome. Conclusions drawn from this study should therefore be viewed with caution while awaiting confirmation by other investigators. Given the limited data on apical margins in RPP, our series provides some evidence that the significance of positive apical surgical margins should not be overemphasized. Also, whereas apical soft tissue samples were obtained via a standardized technique by a single experienced perineal surgeon, sampling variability is reflected in the fact that one to three tissue biopsies were obtained from each patient according to tissue availability. Differential anatomical accessibility to the prostatic fossa overlying the apex may also have had an impact on the samples obtained from each patient. In particular, incomplete sampling may have resulted in an underestimation of the number of cases in which residual cancer was present at the apex. However, despite such limitations, the association of positive apical soft tissue biopsies with biochemical failure suggests that apical soft tissue biopsies may have a potential role in identifying patients at increased risk for local failure who may benefit from early adjuvant treatment.
Conclusions
RPP is effective in achieving negative apical margins in a majority of patients with localized adenocarcinoma of the prostate and documented apical cancer invasion. Apical surgical margins, however, appear to have limited value in predicting residual apical disease as determined by soft tissue biopsies from the apical prostatic fossa. Positive apical soft tissue biopsies, not apical margins, were independent predictors of biochemical failure after RPP and may have a potential role in selecting patients for adjuvant therapy who may be at increased risk of local failure.
